Humoral immune response to epidermal growth factor receptor in lung cancer

Cancer statistics, 2019

Rebecca L. Siegel, Kimberly D. Miller, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2019 · 21K citations · Full text

Medicine, Oncology, Cancer Epidemiology +16

A pathology atlas of the human cancer transcriptome

Mathias Uhlén, Cheng Zhang, Sunjae Lee et al. · Science · 2017 · 3.5K citations · Full text

Medicine, Cancer Biology, Oncology +17

Acquired Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib Is Associated with a Second Mutation in the EGFR Kinase Domain

William Pao, Vincent A. Miller, Katerina Politi et al. · PLoS Medicine · 2005 · 3.5K citations · Full text

Medicine, Oncology, Pharmacology +17

Predictive and Prognostic Impact of Epidermal Growth Factor Receptor Mutation in Non–Small-Cell Lung Cancer Patients Treated With Gefitinib

Sae‐Won Han, Tae‐You Kim, Pil Gyu Hwang et al. · Journal of Clinical Oncology · 2005 · 775 citations · Full text

Medicine, Oncology, Pharmacology +17

Epidermal growth factor receptor expression correlates with poor prognosis in non-small cell lung cancer patients with p53 overexpression.

Yoshinobu Ohsaki, Satoshi Tanno, Yasuko Fujita et al. · Oncology Reports · 2000 · 255 citations

Medicine, Cancer Biology, Oncology +14